Picture of BRAIN Biotech AG logo

BNN BRAIN Biotech AG News Story

0.000.00%
de flag iconLast trade - 00:00
IndustrialsHighly SpeculativeSmall CapMomentum Trap

Brief: BRAIN Biotech Extends Its Genome-Editing Toolbox With Addition Of BRAIN-Metagenome-Cas 01 Nuclease

Dec 8 (Reuters) - BRAIN BIOTECH AG  BNNn.DE :
    * IS EXTENDING ITS PROPRIETARY GENOME-EDITING TOOLBOX WITH
ADDITION OF BRAIN-METAGENOME-CAS 01 (BMC01) NUCLEASE
    * THIS ADDITIONAL NUCLEASE WILL EXTEND BRAIN'S PROPRIETARY
GENOME
EDITING COMPETENCE AND FURTHER ENHANCE OVERALL ECONOMIC
POTENTIAL OF PLATFORM, IN CASE PATENT PROTECTION IS GRANTED

Source text for Eikon:  ID:nEQc9trsHa 
Further company coverage:  BNNn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on BRAIN Biotech AG

See all news